Haematologica is the journal of the European Hematology Association and the Ferrata Storti Foundation.
Haematologica publishes articles in the broad field of hematology, reporting on novel findings in basic, clinical and translational research.
2015 Impact Factor: 6.671
In the April issue
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des MyélodysplasiesIL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts